158 related articles for article (PubMed ID: 7578378)
1. Management of chemotherapy-induced anemia.
Eguchi K
Curr Opin Oncol; 1995 Jul; 7(4):316-9. PubMed ID: 7578378
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
Hansen PB; Johnsen HE; Hippe E; Hellström-Lindberg E; Ralfkiaer E
Am J Hematol; 1993 Dec; 44(4):229-36. PubMed ID: 8237992
[TBL] [Abstract][Full Text] [Related]
3. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
St Onge J; Jacobson RJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
[No Abstract] [Full Text] [Related]
4. Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study).
Wurnig C; Windhager R; Schwameis E; Kotz R; Zoubek A; Stockenhuber F; Kurz RW
Transfusion; 1996 Feb; 36(2):155-9. PubMed ID: 8614967
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
8. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
10. Treatment of anemia in low risk myelodysplastic syndromes with granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin.
Economopoulos T; Mellou S; Papageorgiou E; Pappa V; Kokkinou V; Stathopoulou E; Pappa M; Raptis S
Leukemia; 1999 Jul; 13(7):1009-12. PubMed ID: 10400415
[TBL] [Abstract][Full Text] [Related]
11. [Erythropoiesis stimulating proteins for the treatment of anemia in cancer patients].
Burger S; Lehnert M; Ludwig H
Ther Umsch; 2010 May; 67(5):271-6. PubMed ID: 20509125
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
13. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.
Oberhoff C; Neri B; Amadori D; Petry KU; Gamucci T; Rebmann U; Nowrousian MR; Voigtmann R; Monfardini S; Armand JP; Herrmann R; Netter-Pinon J; Tubiana-Mathieu N; Zwierzina H
Ann Oncol; 1998 Mar; 9(3):255-60. PubMed ID: 9602258
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
Aoki A; Shibata A
Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin for oncology supportive care.
McKinney M; Arcasoy MO
Exp Cell Res; 2011 May; 317(9):1246-54. PubMed ID: 21396935
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
